Adult genitourinary sarcoma: Analysis using hospital-based cancer registry data in Japan

Author:

Nitta Satoshi1ORCID,Kandori Shuya1ORCID,Suzuki Shuhei1,Hamada Kazuki1,Chihara Ichiro1,Shiga Masanobu1,Kojo Kosuke1,Sakka Shotaro1,Nagumo Yoshiyuki1,Kimura Tomokazu1,Mathis Bryan J2,Negoro Hiromitsu1,Okuyama Ayako3,Higashi Takahiro4,Nishiyama Hiroyuki1

Affiliation:

1. University of Tsukuba Faculty of Medicine: Tsukuba Daigaku Igaku Iryokei

2. University of Tsukuba Hospital: Tsukuba Daigaku Fuzoku Byoin

3. Saint Lukes College of Nursing

4. National Cancer Center Japan: Kokuritsu Gan Kenkyu Center

Abstract

Abstract Objectives We aimed to elucidate the clinical characteristics, survival outcomes and prognostic factors for overall survival of adult genitourinary sarcoma in Japan.Methods A hospital-based cancer registry data in Japan was used to identify and enroll patients diagnosed with genitourinary sarcoma in 2013. The datasets were registered from 121 institutions.Results A total of 116 men and 39 women were included, with a median age of 66 years. The most common primary site was the kidney in 47 patients, followed by the paratestis in 36 patients. The most common histological type was liposarcoma in 54 patients, followed by leiomyosarcoma in 25 patients. The 5-year overall survival rates were 57.6%. On univariate analysis, male gender, primary organ of paratestis, histological subtype of liposarcoma, and treatment with surgery were predictive of favorable survival while primary kidney, bladder or prostate gland, and treatment with chemotherapy or radiation were predictive of unfavorable survival. On multivariate analysis, primary paratestis and treatment with surgery were independent predictors of favorable survival while treatment with chemotherapy was an independent predictor of unfavorable survival.Conclusions We revealed clinical characteristics and survival outcomes of adult genitourinary sarcoma in Japan using a real-world large cohort database. Primary paratestis and treatment with surgery or chemotherapy were independent, significant factors for prognosis.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3